ARVO 2021: Novel Topical Antibody Fragment to TNF-α Shows Potential in Treatment of Acute Anterior Uveitis
The investigational agent could become an alternative to corticosteroid treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.